<DOC>
	<DOCNO>NCT02597465</DOCNO>
	<brief_summary>An open label study determine efficacy safety SPARC1507</brief_summary>
	<brief_title>Study SPARC1507</brief_title>
	<detailed_description>Subjects advance Biliary tract carcinoma meeting eligibility criterion randomize study .</detailed_description>
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<criteria>Evidence advanced/metastatic biliary tract cancer Male female ≥ 18 year old Participants must measurable disease accord RECIST ECOG performance status ≤ 1 Known hypersensitivity trial treatment , excipients Prior history treatment taxane therapy Cardiovascular disorder per Investigator 's discretion The subject receive radiation therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>